Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 6/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.33 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | IDH1 | O75874 | 1/20 | 0.33 |
| ▸ | IDH2 | P48735 | 1/20 | 0.33 |
| ▸ | TRPV3 | Q8NET8 | 3/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | IL1B | P01584 | 2/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27377777 | 1.00 | GPR119 (0.36) | GPR119SCN9ASCN5ACNR1CNR2 | |
| SCHEMBL30755381 | 0.88 | P2RX7 (0.35) | IL1BP2RX7 | |
| SCHEMBL27379422 | 0.88 | P2RX7 (0.35) | IL1BP2RX7 | |
| SCHEMBL30755526 | 0.87 | NR1H2 (0.34) | SCN9AIDH1IDH2IL1BP2RX7 | |
| SCHEMBL27379106 | 0.87 | NR1H2 (0.34) | SCN9AIDH1IDH2IL1BP2RX7 | |
| SCHEMBL30755433 | 0.85 | HDAC4 (0.36) | GPR119SCN9ASCN5AIDH1IDH2 | |
| SCHEMBL27379299 | 0.85 | HDAC4 (0.36) | GPR119SCN9ASCN5AIDH1IDH2 | |
| SCHEMBL27374381 | 0.84 | MEN1 (0.35) | GPR119SCN9ASCN5ACNR2IDH1 | |
| SCHEMBL27375857 | 0.81 | MEN1 (0.36) | IDH1IDH2IL1BP2RX7 | |
| SCHEMBL27375374 | 0.81 | ALOX5AP (0.31) | GPR119SCN9ASCN5ACNR2IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4562016-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2024026483-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |